These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14593750)

  • 21. Tiagabine add-on for drug-resistant partial epilepsy.
    Pereira J; Marson AG; Hutton JL
    Cochrane Database Syst Rev; 2002; (3):CD001908. PubMed ID: 12137637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tiagabine.
    Schachter SC
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
    Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
    Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood.
    Dodrill CB; Arnett JL; Deaton R; Lenz GT; Sommerville KW
    Epilepsy Res; 2000 Dec; 42(2-3):123-32. PubMed ID: 11074185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient dystonias in three patients treated with tiagabine.
    Wolańczyk T; Grabowska-Grzyb A
    Epilepsia; 2001 Jul; 42(7):944-6. PubMed ID: 11488897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of tiagabine: summary of 53 trials.
    Leppik IE; Gram L; Deaton R; Sommerville KW
    Epilepsy Res; 1999 Feb; 33(2-3):235-46. PubMed ID: 10094434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tiagabine monotherapy on abilities, adjustment, and mood.
    Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW
    Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H
    Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study.
    Biraben A; Beaussart M; Josien E; Pestre M; Savet JF; Schaff JL; Tourniaire D; Sevestre M; Renault-Djouadi J
    Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tiagabine in clinical practice: effects on seizure control and behavior.
    Vossler DG; Morris GL; Harden CL; Montouris G; Faught E; Kanner AM; Fix A; French JA;
    Epilepsy Behav; 2013 Aug; 28(2):211-6. PubMed ID: 23770680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current data on tiagabine].
    Herranz JL
    Rev Neurol; 2000 Jun; 30 Suppl 1():S137-41. PubMed ID: 10904981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and EEG findings in six patients with altered mental status receiving tiagabine therapy.
    de Borchgrave V; Lienard F; Willemart T; van Rijckevorsel K
    Epilepsy Behav; 2003 Jun; 4(3):326-37. PubMed ID: 12791336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment.
    Eckardt KM; Steinhoff BJ
    Epilepsia; 1998 Jun; 39(6):671-4. PubMed ID: 9637612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tiagabine: the safety landscape.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 6():S10-S13. PubMed ID: 8595787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term safety of using tiagabine in epilepsy].
    Kozik A
    Neurol Neurochir Pol; 2000; 34 Suppl 7():17-22; discussion 22-3. PubMed ID: 11253488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics and indications of tiagabine].
    Casas-Fernández C; Domingo-Jiménez R
    Rev Neurol; 2002 Sep; 35 Suppl 1():S96-S100. PubMed ID: 12373661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin.
    Hogan RE; Bertrand ME; Deaton RL; Sommerville KW
    Epilepsy Res; 2000 Aug; 41(1):23-8. PubMed ID: 10924865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsy.
    Vinton A; Kornberg AJ; Cowley M; Matkovic Z; Kilpatrick C; O'Brien TJ
    J Clin Neurosci; 2005 Feb; 12(2):128-33. PubMed ID: 15749411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures.
    Borowicz KK; Zadrozniak M; Luszczki JJ; Czuczwar SJ
    J Neural Transm (Vienna); 2008 May; 115(5):661-7. PubMed ID: 18193378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tiagabine in drug-resistant epilepsy in children: preliminary study].
    Wendorff J; Popielarczyk M; Zubiel M; Sokołowska D
    Neurol Neurochir Pol; 2000; 34 Suppl 1():221-4. PubMed ID: 10768162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.